Sequella is a clinical-stage pharma company that develops new and better antibiotics to address drug resistant bacterial, fungal, and parasitic infections.
Work Package 7
CHEMISTRY, MANUFACTURING AND CONTROL (CMC)
To synthesize drug substance and manufacture 200,000 sutezolid 200mg tablets under GMP conditions for use in the trial.
DESCRIPTION OF WORK TO BE CONDUCTED
Aurum and Sequella jointly identified TB Alliance as the suitable vendor(s) to synthesize, tablet, package, and stability test sutezolid tablets. The tablets were developed at Piramal Pharma Limited in India at using TB Alliance methods.